Aptose Biosciences Inc. Gains 66.21%

Aptose Biosciences Inc. (APTO:NASDAQ) shot up at $6.1, a gain of 66.2%. On Tue 23 Mar 21, APTO:NASDAQ hit a New 2-Week Intraday High of $4. The stock got featured on our News Catalysts scanner on Tue 23 Mar 21 at 04:26 PM in the 'EARNINGS' category. From Tue 09 Mar 21, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Tue 01 Dec 20 at $7.27 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About Aptose Biosciences Inc. (APTO:NASDAQ)
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology.
Top 10 Gainers:
- HighPoint Resources Corporation (HPR:NYSE), 118.79%
- WISeKey International Holding AG (WKEY:NASDAQ), 100.78%
- Aptose Biosciences Inc. (APTO:NASDAQ), 66.21%
- HOFV (HOFV:NASDAQ), 38.96%
- GigaMedia Limited (GIGM:NASDAQ), 29.6%
- Phoenix New Media Limited (FENG:NYSE), 28.82%
- ShiftPixy, Inc. (PIXY:NASDAQ), 27.68%
- NextDecade Corporation (NEXT:NASDAQ), 23.68%
- CSCW (CSCW:NASDAQ), 22.41%
- FreightCar America, Inc. (RAIL:NASDAQ), 20.06%